Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Stock analysts at Wedbush dropped their Q3 2023 earnings per share (EPS) estimates for shares of Aerovate Therapeutics in a research report issued to clients and investors on Tuesday, August 15th. Wedbush analyst A. Argyrides now expects that the company will post earnings of ($0.65) per share […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) – Stock analysts at Wedbush dropped their Q2 2023 earnings estimates for shares of Aerovate Therapeutics in a note issued to investors on Wednesday, May 17th. Wedbush analyst A. Argyrides now anticipates that the company will post earnings per share of ($0.63) for the quarter, down from their […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) – Equities researchers at Wedbush boosted their Q1 2023 earnings estimates for Aerovate Therapeutics in a research report issued to clients and investors on Thursday, March 30th. Wedbush analyst A. Argyrides now forecasts that the company will post earnings of ($0.51) per share for the quarter, up from […]